11-Year-Old Becomes First UK Patient to Receive Gene Therapy for Sight Loss
11-year-old Catherine L’Estrange receives UK's first gene therapy for Bardet-Biedl syndrome to halt sight loss.
Source: ITV News
Coverage collected under research & medical across both reported articles and community blog posts.
11-year-old Catherine L’Estrange receives UK's first gene therapy for Bardet-Biedl syndrome to halt sight loss.
Source: ITV News
Belite Bio reports promising results for tinlarebant in treating Stargardt disease, showing significant reduction in macular lesion growth.
Source: Investing.com
New research reveals that reduced myelination leads to a thicker visual cortex in individuals born blind.
Source: Technology Networks
NCCU students test smart canes that detect both ground-level and overhead obstacles to aid the visually impaired.
Source: WUNC News
The American Foundation for the Blind (AFB) is at the forefront of research highlighting challenges and barriers faced by the blind and low vision community. From digital inclusion to pandemic impacts, AFB's studies and toolkits provide valuable insights and recommendations for fostering inclusivity.
Source: American Foundation for the Blind
New BCI system enables ALS patient to communicate and use digital devices independently.
Source: UC Davis Health
Johns Hopkins research highlights the navigation challenges faced by adults with concurrent hearing and vision loss, emphasizing the need for tailored rehabilitation.
Source: Johns Hopkins Medicine

UWM professors are developing design guidelines to make digital libraries more accessible for visually impaired users.
Source: Newswise

The American Foundation for the Blind's Journal of Visual Impairment & Blindness remains the leading peer-reviewed publication for research on blindness and visual impairment. The journal accepts submissions from researchers worldwide on topics ranging from assistive technology to educational practices.
Source: American Foundation for the Blind